Report : A-Z NHS England items in Formulary 03/04/2025 13:08:23

[Back]

Section Status NHS England Name 05.03.01 Formulary Abacavir  05.03.01 Formulary Abacavir and Lamivudine  05.03.01 Formulary Abacavir with Dolutegravir and Lamivudine Triumeq® 11.08.02 Formulary Adalimumab  08.02.03 Formulary Alemtuzumab Lemtrada® 09.08.01 Formulary Asfotase alfa Strensiq® 10.02 Formulary Ataluren Translarna ® 05.03.01 Formulary Atazanavir  05.03.01 Formulary Atazanavir sulfate and cobicistat Evotaz® 08.02.02 Formulary Avacopan Tavneos ® 09.08.01 Formulary Avalglucosidase alfa Nexviadyme ® 05.01.02.03 Formulary Aztreonam  05.01.09 Formulary Bedaquiline  03.04.02 Formulary Benralizumab Fasenra® 03.04.03 Formulary Berotralstat dihydrochloride Orladeyo® 13.05.03 Formulary Bimekizumab Bimzelx ® 13.01 Formulary Birch bark extract Filsuvez Gel® 05.03.03 Formulary Bulevirtide  HEPCLUDEX® 06.06.02 Formulary Burosumab Crysvita® 03.04.03 Formulary C1 Esterase Inhibitor Berinert® 05.03.01 Formulary Cabotegravir  Vocabria® 04.08.01 Formulary Cannabidiol  Epidyolex® 09.01.04 Formulary Caplacizumab  Cablivi ® 08.01.03 Formulary Cladribine Mavenclad® 05.03.01 Formulary Cobicistat  05.01.07 Formulary Colistimethate  09.01.03 Formulary Crovalimab Piasky® 09.01.03 Formulary Danicopan  05.03.01 Formulary Darunavir  05.03.01 Formulary Darunavir with Cobicistat Rezolsta® 05.03.01 Formulary Darunavir with Cobicistat, Emtricitabine and Tenofovir alafenamide Symtuza® 05.01.09 Formulary Delamanid  13.03 Formulary Difelikefalin  Kapruvia® 08.02.04 Formulary Dimethyl fumarate Tecfidera® 08.02 Formulary Diroximel Fumarate Vumerity ® 05.03.01 Formulary Dolutegravir and Lamivudine Dovato® 05.03.01 Formulary Dolutegravir and Rilpivirine  Juluca® 05.03.01 Formulary Doravirine Pifeltro® 03.07 Formulary Dornase Alfa  05.03.01 Formulary Efavirenz  09.08 Formulary Eladocagene exuparvovec Upstaza® 01.09.01 Formulary Elafibranor  05.03.03.02 Formulary Elbasvir with grazoprevir  Zepatier® 05.03.01 Formulary Elvitegravir with cobicistat, emtricitabine and tenofovir disoproxil Stribild® 05.03.01 Formulary Emrticitabine with Rilpivirine and Tenofovir disoproxil Eviplera® 05.03.01 Formulary Emtricitabine Emtriva® 05.03.01 Formulary Emtricitabine with Rilpivirine and Tenofovir alafenamide Odefsey® 05.03.01 Formulary Emtricitabine with Tenofovir alafenamide Descovy® 05.03.01 Formulary Enfuvirtide Fuzeon® 09.08.01 Formulary Eplontersen Wainzua® 05.03.01 Formulary Etravirine Intelence® 02.12 Formulary Evinacumab Evkeeza® 04.08.01 Formulary Fenfluramine  Fintepla® 08.02.04 Formulary Fingolimod  05.03.01 Formulary Fostemsavir Rukobia® 08.02.04 Formulary Glatiramer Acetate Copaxone® 05.03.03.02 Formulary Glecaprevir with pibrentasvir Maviret® 14.05 Formulary Human normal immunoglobulin  03.04.03 Formulary Icatibant  08.02 Formulary Imlifidase  Idefirix® 08.02.04 Formulary Interferon Alfa  08.02.04 Formulary Interferon Beta Avonex® 08.02.04 Formulary Interferon Beta Rebif® 08.02.04 Formulary Interferon beta Extavia® 09.01.03 Formulary Iptacopan  05.02 Formulary Isavuconazole  03.07 Formulary Ivacaftor  Kalydeco® 05.03.01 Formulary Lamivudine with tenofovir disoproxil and doravirine Delstrigo® 03.04.03 Formulary Lanadelumab Takhzyro® 13.05.03 Formulary Lebrikizumab  05.03.03.02 Formulary Ledipasvir and Sofosbuvir Harvoni® 05.03.02.02 Formulary Letermovir Prevymis® 04.09.01 Formulary Levodopa-Carbidopa- Entacapone Intestinal Gel (LECIG)  04.09.01 Formulary Levodopa-Carbidopa Intestinal Gel (LCIG)  05.03.01 Formulary Lopinavir and Ritonavir  10.01.04 Formulary Lumasiran Oxlumo ® 09.01.04 Formulary Lusutrombopag Mulpleo® 03.07 Formulary Mannitol Bronchitol ® 05.03.01 Formulary Maraviroc Celsentri® 05.03.02.02 Formulary Maribavir Livtencity® 03.04.02 Formulary Mepolizumab   10.02.02 Formulary Mexiletine hydrochloride Namuscla ® 05.02 Formulary Micafungin  08.02.04 Formulary Natalizumab Tysabri® 05.03.01 Formulary Nevirapine  10.02 Formulary Nusinersen  Spinraza® 08.02.03 Formulary Ocrelizumab Ocrevus® 08.02.03 Formulary Ofatumumab Arzerra® 10.02 Formulary Onasemnogene abeparvovec Zolgensma® 08.02 Formulary Ozanimod Zeposia® 05.03.05 Formulary Palivizumab Synagis® 08.02.02 Formulary Pegcetacoplan  Aspaveli® 08.02.04 Formulary Peginterferon Alfa Pegasys® 08.02.04 Formulary Peginterferon beta‑1a  Plegridy® 06.05 Formulary Pegvisomant  03.11 Formulary Pirfenidone  08.02.04 Formulary Ponesimod Ponvory® 05.01.09 Formulary Pretomanid  05.03.01 Formulary Raltegravir Isentress ® 09.01.03 Formulary Ravulizumab Ultomiris® 03.04.02 Formulary Reslizumab  05.02 Formulary Rezafungin Rezzayo® 05.03.01 Formulary Rilpivirine hydrochloride  10.02 Formulary Risdiplam  Evrysdi® 05.03.01 Formulary Ritonavir  08.02.04 Formulary Ropeginterferon Alfa-2b Besremi® 06.07 Formulary Setmelanotide  Imcivree ® 08.02.04 Formulary Siponimod Mayzent® 05.03.03.02 Formulary Sofosbuvir and Velpatasvir  Epclusa® 05.03.03.02 Formulary Sofosbuvir with Velpatasvir and Voxilaprevir Vosevi® 04.12 Formulary Tafamidis  05.03.01 Formulary Tenofovir 245mg, Efavirenz 600mg and Emtricitabine 200mg  05.03.01 Formulary Tenofovir alafenamide, elvitegravir, cobicistat & emtricitabine  Genvoya® 05.03.01 Formulary Tenofovir and Emtricitabine  05.03.01 Formulary Tenofovir Disproxil  03.04.02 Formulary Tezepelumab  08.02.03 Formulary Ublituximab Briumvi® 08.02.02 Formulary Voclosporin Lupkynis® 11.11 Formulary Voretigene Neparvovec Luxturna® 09.08.01 Formulary Vutrisiran Amvuttra ® 05.03.01 Formulary Zidovudine

Lancashire and South Cumbria